Abstract
OBJECTIVE To investigate the apoptosis-inducing effect of XIAP antisense oligonucleotides on glioblastoma cells in vitro.
METHODS There were 4 groups in our experiment. Group A, as a cell control group, had normal cell culture and no treatment applied. Group B, as a blank control group, had normal cell culture and no liposome control of ASODN. Group C was N-ODN. Group D was the ASODN group. RT-PCR and Western blot assay were conducted to detect the expression of XIAP in all A-172 cell groups after treatment with XIAP antisense oligonucleotides (ASODN). MTT assay and flow-cytometry (FCM) detection were used to detect the ability of cell anchoring growth and apoptotic rates of all groups. The processing time was 72 h.
RESULTS The expression of XIAP in the A-172 cells was greatly down-regulated, after treated with XIAP-ASODN. Among different concentrations of ASODN, the 300nM was the most optimal one. The down-regulation of XIAP obviously inhibited the succinate dehydrogenase (SDH) activity of the A-172 cells and the increased apoptotic rate of A-172 cells (87.45%) was significantly higher than that of the A-172 in the control groups. There was a statistically significant difference between the treatment and control groups (P < 0.01).
CONCLUSION The XIAP-ASODN can effectively regulate the expression of the XIAP down, as a result, inhibit the growth of the glioblastoma cells (A-172) and obviously increase the apoptotic rate of the A-172 cells. The results of the study manifest an overt killing role of XIAP-ASODN to the glioblastoma cells.
keywords
Introduction
Glioblastoma is a highly malignant tumor in the nervous system, which frequently recurs after surgery. Therefore, clinical treatment against glioblastoma has become a cosmopolitan problem. The XIAP was a newly-found inhibiting factor of apoptosis over the past few years. The antisense oligodeoxynucleotide technology was used to block the expressions of the apoptotic inhibitor in order to attain the increased apoptosis of tumor cells. Therefore, the ASODN has driven more and more concerns of the oncologists and researchers to the apoptosis-inducing treatment of tumors[1]. In our study, the method of positive-ion, liposome-mediated XIAP-ASODN transfecting the A-172 cells in vitro was used, and the roles of XIAP-ASODN in growth inhibition and apoptosis induction on glioblastoma were observed, thus providing experimental bases for the application of XIAP-ASODN in clinical treatment against glioblastoma.
Materials and Methods
Main materials
The A-172 human glioblastoma cells were bought from the Shanghai Cytology Research Institute. The cell-transfection kit was bought from the GIBICO, USA. The one-step RT-PCR kit was bought from the TaKaRa BioTech Co. Ltd., Japan. In combination with literature, an ASODN containing 19 basic groups was artificially synthetized with the coding regions at No.251-269, and the nucleotide of XIAP mRNA was 5’-GCT GAG TCT CCA TAT TGC C-3’. At the same time, the non-relevant serial oligodeoxynucleotid (N-ODN) was designed with the sequence of 5’-AGA GAT TCC GAT CCG T-3’, with phosphorothioate oligonucleotide and PAGE purification. The N-ODN was synthetized by the Beijing AuGCT Bioengineering Co., China. The homology wasn’t found between the ASODN and human gene after computer retrieval. XIAP primer‘s upstream was 5’-CAC TTG AGG TTC TGG TTG CAG-3’; and its downstream 5’-CTT-GTCAACTGCTTCAGCACA-3’, of which amplified fragment was 204 bp. The β-actin primer’s upstream was 5’-GAT AAA GTA AAG TGC TTT CAC TGT-3’ and its downstream was 5’-GTA GTT CTT ACC AGA CAC TCC TCA A-3’, of which amplified fragment was 308 bp.
Methods
The cell culture, grouping and transfection: The refrigerated A-172 human glioblastoma cell lines was inoculated in a 25-cm2 culture flask after anabiosis at a water temperature of 37°C. A DMEM medium added with a 15% heat-inactivated fetal bovine serum was used. Then the cells were put into the incubator containing 5% CO2 with ample saturated concentration at 37°C. The medium was changed on alternate days until the bottom of culture flask was besprent with the cells. The trypsin digestion and cell counting were conducted 1 day before the treatment, and the cells were inoculated on a 96-hole plate and in a 25-cm2 culture flask respectively, based on the quantity of 5 × 103/hole and 1 × 105/flask. Then the cells were put into the incubator with 5% CO2 at 37°C for an overnight. The cell transfection was conducted strictly based on instructions of the transfection kit.
Overall RNA extraction and RT-PCR
Cell dissociation was conducted using 0.2% trypsin digestion and centrifugated 72 h after treatment. Uni-cell suspensions in each group were respectively prepared, and cell counting was conducted. A 1 × 106 cell was put into a new 0.5-ml EP-tube, and a 3000-rpm centrifugation was performed at 4°C for 10 min, forming cell assemblies. Supernatant was carefully removed, and 1 ml of Trizol was added in the tube. Repeated blow using a transferpettor tip was carried out, and after the vibration, a static culture of the cell was conducted at room temperature for 5 min. After adding a 200 μl of chloroform, vibrate the tube for 15 sec so as to make the cultured cells in the tube were sufficiently mixed and then left the tube at 4°C for 3 min followed by the procedure of centrifugation at 12,000 rpm for 15 min.
The supernatant was carefully moved into a 1.5-ml sterilized, centrifuge tube without RNase in it. After the isovolumic pre-cooling isopropanol (-20°C) was added in and mixed, the tube had an ice bath at 4°C for 10 min and then was centrifugated at 1,2000 rpm for 15 min. Then the supernatant was discarded, and the liquid was absorbed using the absorbent. A 1-ml 75% glacial alcohol (prepared by DEPC water) was added in and mixed at 4° C followed by the centrifugation at 8000 rpm for 5 min, and then the supernatant was discarded. The liquid was trickled out from absorbent paper, with airing at room temperature for 20 min. A 20-30 μl of DEPC water was added in, and the available solution was the right RNA sample.
One-step method was used for RT-PCR, with 25-μl reaction system. The treatment was conducted strictly based on specifications of the RT-PCR kit. The amplification includes the following procedures: i) 50°C, 30 min and initial denaturation at 94°C, 2 min; ii) denaturation at 94°C, 30 sec, renaturation at 58°C, 30 sec, with a phase of extension in the PCR at 72°C for 1 min. The above procedures were repeated for 30 cycles.
Western blot assay
In the following procedures of collection and treatment of A-172 cells, the protein samples were prepared by boiling and centrifugalization after clearage, and then transferred to nitrocellulose filter (NC filter) after gelatum separation using 6% polyacrylamide gel electrophoresis. Finally chemiluminescence reagents were used for detection of the XIAP protein. Biogel imaging analytical system was used for scanning to determine the grey-scale value, and then the specific values of the experiment groups/cell control group were calculated, so as to obtain the relative expression of proteins.
MTT method for assaying the activity of cell proliferation
A 96-hole plate was used for the treatment of the cells, which lasted for 72 h. Under a circumstance of reserving the DMEM, a 20 μl of MTT solution was added in each hole, and then the cell culture was conducted in the incubator with a 5% culture solution at 37°C for 4 h. The supernatant cultured in the holes of DMEM was carefully extracted and discarded, after that, a 150 μl of dimethyl sulfoxide (DMSO) was added in each hole, followed by the vibration for 10 min so as to allow the crystals fully dissolved. The 550-nm wavelength of photoabsorption value in each hole was detected on a microplate scanning spectrophotometer, and the outcomes were recorded. The inhibition of succinate dehydrogenase (SDH) activity in cells was regarded as the outcome of determination in this assay. Computational formula is that the inhibition ratio of SDH activity (%) = (1− the absorption value of experiment groups/absorption value of control group) × 100%.
Detection of apoptosis by flow-cytometry (FCM)
A-172 cells were prepared to be the cell suspension after the digestion process, and were determined using the Annexin V-FITC and PI double-staining methods. The judgment standards in the FCM chart were as follows: Q1 zone: PI (+) Annexin V (-) regarded as necrotic cell zone; Q2 zone: PI (+) Annexin V (+) as late apoptosis or dead cell zone; Q3 zone: PI (-) Annexin V (-) as living cell zone; Q4 zone: PI (-) Annexin V (+) as viable apoptotic cell zone. The result from the statistical analysis of the apoptosis was Q2 + Q4.
Statistical analysis
The statistical data were tested using mean ± SD deviation, and the SPSS13.0 software was sued for χ2 test of the correlated data. The value of P < 0.01 was considered as statistically significant.
Results
RT-PCR results
After applying the XIAP-ASODN, the expression of XIAP mRNA was significantly decreased in the A-172 cells (Group D) (Fig. 1).
Expression of XIAP mRNA in the A-172 cells of each group after XIAP-ASOND treatment
Western blot results
After using the XIAP-ASODN blockade, the XIAP protein expression was obviously decreased in the A-172 cells (Fig. 2 and Table 1).
Expression of XIAP protein in the A-172 cells of each group after XIAP-ASOND treatment
Expression of XIAP protein in the A-172 cells after treatment
Results of MTT reduction assay
XIAP-ASODN significantly inhibited the activity of A-172 cell proliferation. There were statistical significance in the differences between the treatment and the control groups, P < 0.01 (Table 2).
Inhibitory effect of XIAP-ASDON on the SDH activity of A-172 cells
Results of FCM detection
The results of the flow cytometry showed that profuse apoptosis of the A-172 cells occurred after XIAP-ASOND treatment. There were significant differences in the rate of the apoptosis between the treatment group and the control groups, P < 0.01 (Table 3).
Results of the FITC/PI double-staining in the A-172 cells after treatment (%)
Discussion
Glioblastoma is a highly malignant tumor in the nervous system. The clinical treatment against the glioblastoma has been a worldwide problem for a long time. For the past few years, apoptosis-inducing treatment of tumor has become a new strategy in clinical researches. Apoptosis is the course of cell sequencing death resulted from the change of the internal and external environments or trigger of dead signal, as well as gene regulation. Medical studies unceasingly certify that the impairment or loss of the apoptosis is one of the important factors in occurrence and progression of tumors[2]. Therefore, to facilitate apoptosis of the tumor cells has become a direction of significance in the modern researches on tumor treatment. Inhibitor of apoptosis protein (IAPs)[3-7] is a member of cyto-endogenous IAPs family with a homology in the structure. XIAP is one of the most efficient inhibitors in the IAPs family, and also is one of the IAPs family members with the most distinct molecular constitution. It was shown in the studies that there was a correlation between an over-expression of XIAP in tumor cells and durative survival of the tumor cells, and the XIAP expression probably participated in the occurrence and progression of the tumor[8].
The antisense oligonucleotides technology is a specific oligonucleotide made by a complementation fixation of a artificially synthetized energy with RNA or DNA, resulting in a specific inhibition of the gene expression. In our experiment, an ASODN complementary to XIAP mRNA was contrived and synthetized, and the lethal effect of XIAP-ASODN on A-172 cells was observed through the blockade of XIAP expression in cell transfection. The experimental result was satisfactory.
In our experiment, the inhibition of XIAP-ASODN on activity of the A-172 cell proliferation was observed. All 5 different concentrations of XIAP-ASODN resulted in definite inhibition effects on the A-172 cell activity, and the inhibition ratio was increased with the increasing concentration of the XIAP-ASODN, showing a concentration dependent feature. It was similar to the experimental results of other studies[1,9]. Likewise, however, when the concentration of the XIAP-ASODN stepped up to a certain value, the increment extent of inhibition was reduced. In this experiment, when the concentration of the XIAP-ASODN was 300 nM, the inhibition ratio attained 49.67%, and when the concentration was 400 nM, the inhibition ratio was 50.44%. No significant differences in the concentrations of 300 nM and 400 nM were found (P > 0.05). Therefore, the value of 300 nM has become optimal concentration of the medication in our experiment.
The cation liposome mediation, a method of the gene mediation into the cells used in our experiment, has the characteristics of avirulence, high efficiency, convenience and practice. After the A-172 cells were transfected using the cation liposome-mediated phosphorothioate-type XIAP-ASODN, the XIAP-ASODN can be effectively taken by the cells, but they were not degraded by nucleic acid in extracellular environment. It can achieve the concentration for effectively combining with target gene in the cells, thus having specificity of blocking the target gene. The direct role of XIAP-ASODN, after its access into the cell, is to block the expression of XIAP mRNA and affect its post-transcriptional level and protein expression. The RT-PCR outcome in this experiment showed that after the A-172 cells were transfected using the XIAP-ASODN, there was significant down-regulation in the XIAP mRNA expression. The down-regulation of XIAP mRNA expression also influenced the expression of XIAP protein. Western blotting results showed that the expression of XIAP protein was decreased 62.28%. Comparing the expression of XIAP protein in the treatment group with those in the cell control, blank control and non-relevant serials control groups, there were significant differences (P < 0.01). At the same time, we have also found that following an XIAP-ASODN transfection of A-172 cells for 72 h, the FCM of the apoptosis was obviously increased, with an apoptotic rate of 75.88%, therefore, the apoptotic rate between the treatment group and the control groups were statistically different (P < 0.01). The results of our experiment forcefully confirms that the XIAP-ASODN can really produce apparent inhibition and lethal effect on theA-172 cells through down-regulation of the XIAP expression, which demonstrate the important facts to support the theory that the XIAP-ASODN can be applied in the clinical treatment against glioblastomas.
- Received October 10, 2008.
- Accepted April 5, 2009.
- Copyright © 2009 by Tianjin Medical University Cancer Institute & Hospital and Springer